Douglas E. Joshua

Phospho-flow detection of constitutive and cytokine-induced pSTAT3/5, pAKT and pERK expression highlights novel prognostic biomarkers for patients with multiple myeloma

C. Weatherburn, D. Joshua, D. Hart, 2014, Leukemia.

The failure of immune checkpoint blockade in multiple myeloma with PD-1 inhibitors in a phase 1 study

D. Joshua, R. Brown, J. Gibson, 2015, Leukemia.

Multiple myeloma causes clonal T-cell immunosenescence: identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade

N. Nassif, C. Weatherburn, D. Joshua, 2016, Leukemia.

Serum Free Light Chain Kinetics Is Predictive of Renal Response in Myeloma Patients With Renal Impairment-An ALLG Trial of Carfilzomib-Dexamethasone Therapy in Frontline and Relapse.

A. Enjeti, N. Horvath, P. J. Ho, 2024, Clinical lymphoma, myeloma & leukemia.